Mergers and acquisitions deals as a form of business development: evidence from pharmaceutical companies
Published: 10 May 2023| Version 1 | DOI: 10.17632/g3gh9r9px2.1
Contributor:
Daria Medvedeva
Description
Public data on completed M&A and financial performance of companies in the global pharmaceutical industry for the period from 2010 to 2020
Files
Steps to reproduce
You must use Stata econometric package to reproduce the results of the empirical part of the research. For more information about the specification of models, the choice of the optimal model (a model with random effects for H1 and H3, a model with fixed effects for H2), see the text of the research.
Categories
Binary Composite, Financial Analysis, Panel Data Model